Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Zimenkov, Danila V ^a   Antonova, Olga V ^a   Kuz'min, Alexey V ^c   Isaeva, Yulia D ^b   Krylova, Ludmila Y ^b   Popov, Sergey A ^c   Zasedatelev, Alexander S ^a   Mikhailovich, Vladimir M ^a   Gryadunov, Dmitry A ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b MOSCOW HEALTHCARE DEPARTMENT   (Russian Federation)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Biochips; Extensively drug resistant tuberculosis; Hybridisation; Oligonucleotide microarrays; XDR TB

Indexed keywords

CAPREOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; ETHAMBUTOL; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM ISOLATE; BIOCHIP; CONTROLLED STUDY; DNA MICROARRAY; EIS GENE; GENE MUTATION; GYRA GENE; GYRB GENE; LUNG LAVAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROMOTER REGION; RRS GENE; SENSITIVITY AND SPECIFICITY; SPUTUM; URINE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA GYRASE; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84878004393     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-240     Document Type: Article

References (30)

1. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2011, 55(5):2032-2041. 10.1128/AAC.01550-10, 3088277, 21300839.
2. Pantel A, Petrella S, Matrat S, Brossier F, Bastian S, Reitter D, Jarlier V, Mayer C, Aubry A. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2011, 55(10):4524-4529. 10.1128/AAC.00707-11, 3186962, 21768507.
3. Malik S, Willby M, Sikes D, Tsodikov OV, Posey JE. New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations. PLoS One 2012, 7(6):e39754. 10.1371/journal.pone.0039754, 3386181, 22761889.
4. Aubry A, Veziris N, Cambau E, Truffot-Pernot C, Jarlier V, Fisher LM. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrob Agents Chemother 2006, 50(1):104-112. 10.1128/AAC.50.1.104-112.2006, 1346799, 16377674.
5. Veziris N, Martin C, Brossier F, Bonnaud F, Denis F, Aubry A. Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance. Eur J Clin Microbiol Infect Dis 2007, 26(6):423-425. 10.1007/s10096-007-0298-0, 17458568.
6. Kim H, Nakajima C, Yokoyama K, Rahim Z, Kim YU, Oguri H, Suzuki Y. Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance. Antimicrob Agents Chemother 2011, 55(8):3661-3667. 10.1128/AAC.00042-11, 3147658, 21646485.
7. Pantel A, Petrella S, Veziris N, Brossier F, Bastian S, Jarlier V, Mayer C, Aubry A. Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis. Antimicrob Agents Chemother 2012, 56(4):1990-1996. 10.1128/AAC.06272-11, 3318379, 22290942.
8. Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother 2012, 67(4):819-831. 10.1093/jac/dkr566, 3299416, 22279180.
9. Suzuki Y, Katsukawa C, Tamaru A, Abe C, Makino M, Mizuguchi Y, Taniguchi H. Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol 1998, 36(5):1220-1225. 104803, 9574680.
10. Zaunbrecher MA, Sikes RD, Metchock B, Shinnick TM, Posey JE. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2009, 106(47):20004-20009. 2785282, 19906990.
11. Maus CE, Plikaytis BB, Shinnick TM. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005, 49(2):571-577. 10.1128/AAC.49.2.571-577.2005, 547314, 15673735.
12. Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC. Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review. PLoS One 2012, 7(3):e33275. 10.1371/journal.pone.0033275, 3315572, 22479378.
13. Hillemann D, Rusch-Gerdes S, Richter E. Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2009, 47(6):1767-1772. 10.1128/JCM.00081-09, 2691112, 19386845.
14. Feuerriegel S, Cox HS, Zarkua N, Karimovich HA, Braker K, Rusch-Gerdes S, Niemann S. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob Agents Chemother 2009, 53(8):3353-3356. 10.1128/AAC.00050-09, 2715645, 19470506.
15. Engstrom A, Morcillo N, Imperiale B, Hoffner SE, Jureen P. Detection of First- and Second-Line Drug Resistance in Mycobacterium tuberculosis Clinical Isolates by Pyrosequencing. J Clin Microbiol 2012, 50(6):2026-2033. 10.1128/JCM.06664-11, 3372151, 22461677.
16. Gryadunov D, Dementieva E, Mikhailovich V, Nasedkina T, Rubina A, Savvateeva E, Fesenko E, Chudinov A, Zimenkov D, Kolchinsky A. Gel-based microarrays in clinical diagnostics in Russia. Expert Rev Mol Diagn 2011, 11(8):839-853. 10.1586/erm.11.73, 22022946.
17. WHO Laboratory Services in Tuberculosis Control. Part II: Microscopy. WHO/TB/98258 1998, 1-62. Geneva: WHO, WHO.
18. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997, 35(4):907-914. 229700, 9157152.
19. Rodrigues C, Jani J, Shenai S, Thakkar P, Siddiqi S, Mehta A. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. Int J Tuberc Lung Dis 2008, 12(12):1449-1455.
20. WHO Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs. WHO/HTM/TB/2008392 2008, 1-20. Geneva: WHO, WHO.
21. Rubina AY, Pan'kov SV, Dementieva EI, Pen'kov DN, Butygin AV, Vasiliskov VA, Chudinov AV, Mikheikin AL, Mikhailovich VM, Mirzabekov AD. Hydrogel drop microchips with immobilized DNA: properties and methods for large-scale production. Anal Biochem 2004, 325(1):92-106. 10.1016/j.ab.2003.10.010, 14715289.
22. Gryadunov D, Mikhailovich V, Lapa S, Roudinskii N, Donnikov M, Pan'kov S, Markova O, Kuz'min A, Chernousova L, Skotnikova O. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin Microbiol Infect 2005, 11(7):531-539. 10.1111/j.1469-0691.2005.01183.x, 15966970.
23. Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK, AuYeang CK, Yeung CY, Kam KM, Yip PC. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2007, 59(5):866-873. 10.1093/jac/dkm054, 17360809.
24. Zhou J, Dong Y, Zhao X, Lee S, Amin A, Ramaswamy S, Domagala J, Musser JM, Drlica K. Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J Infect Dis 2000, 182(2):517-525. 10.1086/315708, 10915083.
25. Yin X, Yu Z. Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. J Infect 2010, 61(2):150-154. 10.1016/j.jinf.2010.05.001, 20452372.
26. Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2010, 48(5):1683-1689. 10.1128/JCM.01947-09, 2863904, 20335420.
27. Von Groll A, Martin A, Jureen P, Hoffner S, Vandamme P, Portaels F, Palomino JC, da Silva PA. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob Agents Chemother 2009, 53(10):4498-4500. 10.1128/AAC.00287-09, 2764174, 19687244.
28. Engstrom A, Perskvist N, Werngren J, Hoffner SE, Jureen P. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 2011, 66(6):1247-1254. 10.1093/jac/dkr109, 21427106.
29. Huang WL, Chi TL, Wu MH, Jou R. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2011, 49(7):2502-2508. 10.1128/JCM.00197-11, 3147822, 21562102.
30. Nikolayevskyy V, Balabanova Y, Simak T, Malomanova N, Fedorin I, Drobniewski F. Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin Pathol 2009, 9:2. 10.1186/1472-6890-9-2, 2660363, 19284561.